TACI/TNFRSF13B/CVID Antibody (MM0562-9D22), PerCP, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB344321-Each-of-1 | In Stock | ₹ 50,285.00 |
NB344321 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 50,285.00
GST (18%): ₹ 9,051.30
Total Price: ₹ 59,336.30
Antigen
TACI/TNFRSF13B/CVID
Classification
Monoclonal
Conjugate
PerCP
Formulation
PBS
Host Species
Mouse
Purification Method
Protein G purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Neutralization
Clone
MM0562-9D22
Dilution
Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Block/Neutralize
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Immunogen
Human recombinant TACI/TNFRSF13B/CVID (extracellular domain)
Quantity
0.1 mL
Research Discipline
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4C in the dark.
Isotype
IgG1
Related Products
Description
- TACI/TNFRSF13B/CVID Monoclonal antibody specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Neutralization